BioNTainer Units Installed in Melbourne, Boosting Local mRNA Capabilities
The Victorian government has announced the installation of BioNTainer units at BioNTech's facility in Bundoora, marking a key step in a partnership to develop mRNA vaccine and treatment capabilities. The units are located within La Trobe University's University City precinct, a $5 billion development.
Facility Overview
The units are modular, portable laboratories designed for small-scale manufacturing of mRNA-based vaccines and treatments. Their primary function is to support research and development within the local mRNA ecosystem.
The two units have been named Wirrarap and Boordup in the Woi wurrung language. Victoria is one of only two locations globally where BioNTainer units are being deployed.
Economic & Industry Context
According to state government projections, the installation is expected to support up to 1,200 jobs in the wider industry over the next 10 years. Victoria is now home to two leading mRNA vaccine manufacturers, Moderna and BioNTech.
This investment supports both medical research and economic growth.
Stakeholder Statements
Minister Steve Dimopoulos stated that the investment supports medical research and economic growth.
Deputy Premier Ben Carroll said the facilities accelerate the process from scientific discovery to medical treatments.
BioNTech COO Dr. Sierk Poetting stated that the units aim to support the local mRNA ecosystem by providing small-scale manufacturing capabilities focused on research and development.
La Trobe University Vice-Chancellor Professor Theo Farrell described the installation as an important step in developing a world-class innovation ecosystem at the University City precinct.